Discover the range of academic oncology titles at Springer Nature here.
Collections open for submissions: Call for papers
© wildpixel / Getty Images / iStock
Noncoding RNAs as biomarkers
This series, guest edited by Prof. Hua Zhang (Guangdong Medical University, China), will focus on noncoding RNAs to serve as biomarkers for diagnosis, prognosis, as well as therapy in both malignant and non-malignant disorders.
© metamorworks / Getty Images / iStock
Radiogenomic biomarkers
For this collection, guest edited by Dr. Jeon-Hor Chen (University of California, Irvine), we cordially invite manuscripts from different disciplines. High quality manuscripts related to disease diagnosis, prediction of treatment response, and assessment of disease risk and outcome are encouraged. Manuscripts outside of these topics which are within the scope of translational research are also welcome.
CAHON: Stop hate crimes and racism
The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond.
Articles
-
-
Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
-
Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications
-
Sestrin2 in cancer: a foe or a friend?
-
The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
-
The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer
-
Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases
-
Metabolomic analyses for atherosclerosis, diabetes, and obesity
-
Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives
-
Roles of IFN-γ in tumor progression and regression: a review
Springer Nature Oncology Portfolio
Editors-in-Chief
Chung-Tsen Hsueh, Loma Linda University
Delong Liu, New York Medical College
Aims and scope
Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines. Read more.
Announcing the launch of In Review
Biomarker Research, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Follow
Annual Journal Metrics
-
Speed
13 days to first decision for all manuscripts
30 days to first decision for reviewed manuscripts only
72 days from submission to acceptance
15 days from acceptance to publicationCitation Impact
6.148 - 2-year Impact Factor
5.722 - 5-year Impact Factor
1.452 - Source Normalized Impact per Paper (SNIP)
1.633 - SCImago Journal Rank (SJR)
Usage
501,310 Downloads (2021)
73 Altmetric mentions
On the blog
-
Cancer champions – to the local community center… and beyond!
03 February 2022
-
-
Screening for kidney cancer in Leeds
16 April 2021
